Stephen G Pauker

Summary

Affiliation: Tufts-New England Medical Center
Country: USA

Publications

  1. ncbi The clinical interpretation of research
    Stephen G Pauker
    Tufts-New England Medical Center, Boston, Massachusetts, United States of America
    PLoS Med 2:e395. 2005
  2. ncbi Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
    Deeb N Salem
    Department of Medicine, Tufts New England Medical Center, 750 Washington Street, Boston, MA 02111, USA
    Chest 133:593S-629S. 2008
  3. ncbi Systematic review of outcomes after surgical management of venous disease incorporating subfascial endoscopic perforator surgery
    John A TenBrook
    Division of Clinical Decision Making, Department of Medicine, Tufts New England Medical Center, Boston, MA 02111, USA
    J Vasc Surg 39:583-9. 2004
  4. ncbi Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis
    Yoav Golan
    Division of Geographic Medicine and Infectious Diseases, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
    Ann Intern Med 143:857-69. 2005
  5. ncbi Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism
    Joseph A Johnston
    The Health Services Research and Development Service, Veterans Affairs Medical Center, Cincinnati, Ohio, USA
    Am J Med 118:503-14. 2005
  6. ncbi Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
    Deeb N Salem
    Tufts New England Medical Center, 750 Washington St, Boston, MA 02111, USA
    Chest 126:457S-482S. 2004
  7. ncbi Preventing sudden cardiac death: can we afford the benefit?
    Stephen G Pauker
    Ann Intern Med 142:664-6. 2005
  8. ncbi Presidential reflections on the 25th anniversary of the society for medical decision making
    Arthur S Elstein
    Department of Medical Education, University of Illinois at Chicago, USA
    Med Decis Making 24:408-20. 2004
  9. ncbi Information on cost-effectiveness: an essential product of a national comparative effectiveness program
    Neil Kirschner
    Ann Intern Med 148:956-61. 2008
  10. ncbi Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
    Gordon H Guyatt
    Health Sciences Centre, McMaster University, Hamilton, Ontario, Canada
    Chest 133:123S-131S. 2008

Collaborators

Detail Information

Publications11

  1. ncbi The clinical interpretation of research
    Stephen G Pauker
    Tufts-New England Medical Center, Boston, Massachusetts, United States of America
    PLoS Med 2:e395. 2005
  2. ncbi Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
    Deeb N Salem
    Department of Medicine, Tufts New England Medical Center, 750 Washington Street, Boston, MA 02111, USA
    Chest 133:593S-629S. 2008
    ..For patients with infective endocarditis, we recommend against antithrombotic therapy, unless a separate indication exists (Grade 1B)...
  3. ncbi Systematic review of outcomes after surgical management of venous disease incorporating subfascial endoscopic perforator surgery
    John A TenBrook
    Division of Clinical Decision Making, Department of Medicine, Tufts New England Medical Center, Boston, MA 02111, USA
    J Vasc Surg 39:583-9. 2004
    ..Patients in whom conservative therapies fail may improve after surgical treatment of superficial and perforating venous disease, but the degree of this benefit is uncertain...
  4. ncbi Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis
    Yoav Golan
    Division of Geographic Medicine and Infectious Diseases, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
    Ann Intern Med 143:857-69. 2005
    ..Mortality from invasive candidiasis is high. Low culture sensitivity and treatment delay contribute to increased mortality, but nonselective early therapy may result in excess costs and drug resistance...
  5. ncbi Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism
    Joseph A Johnston
    The Health Services Research and Development Service, Veterans Affairs Medical Center, Cincinnati, Ohio, USA
    Am J Med 118:503-14. 2005
    ..The balance of risks and benefits in women with different recurrence risks has not been examined...
  6. ncbi Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
    Deeb N Salem
    Tufts New England Medical Center, 750 Washington St, Boston, MA 02111, USA
    Chest 126:457S-482S. 2004
    ..For patients with bioprosthetic valves who are in sinus rhythm and do not have AF, we recommend long-term (> 3 months) therapy with aspirin, 75 to 100 mg/d (Grade 1C+)...
  7. ncbi Preventing sudden cardiac death: can we afford the benefit?
    Stephen G Pauker
    Ann Intern Med 142:664-6. 2005
  8. ncbi Presidential reflections on the 25th anniversary of the society for medical decision making
    Arthur S Elstein
    Department of Medical Education, University of Illinois at Chicago, USA
    Med Decis Making 24:408-20. 2004
  9. ncbi Information on cost-effectiveness: an essential product of a national comparative effectiveness program
    Neil Kirschner
    Ann Intern Med 148:956-61. 2008
    ....
  10. ncbi Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
    Gordon H Guyatt
    Health Sciences Centre, McMaster University, Hamilton, Ontario, Canada
    Chest 133:123S-131S. 2008
    ..Weak (Grade 2) suggestions require more judicious application, particularly considering patient values and preferences and, when resource limitations play an important role, issues of cost...
  11. ncbi The discrepancy between observational studies and randomized trials of menopausal hormone therapy: did expectations shape experience?
    Nananda F Col
    Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, and Tufts New England Medical Center, Boston, Massachusetts 02120, USA
    Ann Intern Med 139:923-9. 2003
    ..Beliefs held by patients, clinicians, and investigators might have affected the ascertainment of CHD outcomes in observational studies...